Acute coronary syndrome in human immunodeficiency virus-infected patients: Characteristics and 1 year prognosis

European Heart Journal

Volumn 32, Issue 1, 2011, Pages 41-50

  Boccara, Franck ^a,b   Mary Krause, Murielle ^c,d   Teiger, Emmanuel ^e   Lang, Sylvie ^a   Lim, Pascal ^e   Wahbi, Karim ^f   Beygui, Farzin ^g   Milleron, Olivier ^h   Gabriel Steg, Philippe ^c,i,j   Funck Brentano, Christian ^c,d,g   Slama, Michel ^k   Girard, Pierre Marie ^l   Costagliola, Dominique ^c,d,g   Cohen, Ariel ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b CENTRE DE RECHERCHE SAINT ANTOINE   (France)

^c INSERM   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f APHP ^*  (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h Centre Hospitalier Intercommunal Le Raincy Montfermeil   (France)

ⁱ UNIVERSITÉ PARIS DESCARTES   (France)

^j BICHAT HOSPITAL   (France)

^k HÔPITAL ANTOINE BÉCLÈRE   (France)

^l HÔPITAL SAINT ANTOINE   (France)

more..

Author keywords

Acute coronary syndrome; Antiretroviral therapy; HIV infection; Percutaneous coronary intervention

Indexed keywords

ANGIOTENSIN ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; ILLICIT DRUG; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CORONARY RISK; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HAZARD RATIO; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RESTENOSIS; SECONDARY PREVENTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ADULT; ANGIOPLASTY, BALLOON, CORONARY; ANTI-HIV AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOSPITALIZATION; HUMANS; INTENSIVE CARE; KAPLAN-MEIER ESTIMATE; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; PROSPECTIVE STUDIES; THROMBOLYTIC THERAPY;

EID: 78651329629     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehq372     Document Type: Article

References (25)

1. Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 2003;17:2479-2486.
2. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiebaut R, De Wit S, Kirk O, Fontas E, Law MG, Phillips A, Lundgren JD. Class of antiretro-viral drugs and the risk of myocardial infarction. N Engl J Med 2007;356: 1723-1735.
3. El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fatkenheuer G, Gazzard B, Grund B, Hoy J, Klingman K, Losso M, Markowitz N, Neuhaus J, Phillips A, Rappoport C. CD4 + count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355:2283-2296.
4. Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr 2006;43:27-34.
5. Lewden C, May T, Rosenthal E, Burty C, Bonnet F, Costagliola D, Jougla E, Semaille C, Morlat P, Salmon D, Cacoub P, Chêne G, on behalf of the ANRS EN19 Mortalité Study Group and Mortavic. Changes in causes of death among adults infected by HIV between 2000 and 2005: the "Mortalite 2000 and 2005" Surveys (ANRS EN19 and Mortavic). J Acquir Immune Defic Syndr 2008;48: 590-598.
6. Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007;92:2506-2512.
7. Obel N, Thomsen HF, Kronborg G, Larsen CS, Hildebrandt PR, Sorensen HT, Gerstoft J. Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis 2007;44:1625-1631.
8. Saves M, Chene G, Ducimetiere P, Leport C, Le Moal G, Amouyel P, Arveiler D, Ruidavets JB, Reynes J, Bingham A, Raffi F. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 2003;37:292-298.
9. Stein JH. Cardiovascular risk in patients with human immunodeficiency virus infection: incomplete data. J Am Coll Cardiol 2006;47:1124-1125.
10. David MH, Hornung R, Fichtenbaum CJ. Ischemic cardiovascular disease in persons with human immunodeficiency virus infection. Clin Infect Dis 2002;34: 98-102.
11. Escaut L, Monsuez JJ, Chironi G, Merad M, Teicher E, Smadja D, Simon A, Vittecoq D. Coronary artery disease in HIV infected patients. Intensive Care Med 2003;29:969-973.
12. Matetzky S, Domingo M, Kar S, Noc M, Shah PK, Kaul S, Daar E, Cercek B. Acute myocardial infarction in human immunodeficiency virus-infected patients. Arch Intern Med 2003;163:457-460.
13. Ambrose JA, Gould RB, Kurian DC, DeVoe MC, Pearlstein NB, Coppola JT, Siegal FP. Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection. Am J Cardiol 2003;92:301-303.
14. Varriale P, Saravi G, Hernandez E, Carbon F. Acute myocardial infarction in patients infected with human immunodeficiency virus. Am Heart J 2004;147: 55-59.
15. Hsue PY, Giri K, Erickson S, MacGregor JS, Younes N, Shergill A, Waters DD. Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection. Circulation 2004;109:316-319.
16. Boccara F, Teiger E, Cohen A, EDerhy S, Janower S, Odi G, Di Angelantonio E, Barbarini G, Barbaro G. Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis. Heart 2006;92:543-544.
17. Segev A, Cantor WJ, Strauss BH. Outcome of percutaneous coronary intervention in HIV-infected patients. Catheter Cardiovasc Interv 2006;68:879-881.
18. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-969.
19. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA 2004;291:2727-2733.
20. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM. Coronary morphologic and clinical determinants of procedural outcome with angio-plasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation 1990;82:1193-1202.
21. Herlitz J, Karlson BW, Sjolin M, Lindqvist J. Ten year mortality in subsets of patients with an Acute Coronary syndrome. Heart 2001;86:391-396.
22. Periard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, Marcovina SM, Glauser MP, Nicod P, Darioli R, Mooser V. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation 1999;100:700-705.
23. Hsue PY, Hunt PW, Sinclair E, Bredt B, Franklin A, Killian M, Hoh R, Martin JN, McCune JM, Waters DD, Deeks SG. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS 2006;20:2275-2283.
24. Zimmerman FH, Cameron A, Fisher LD, Ng G. Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995;26: 654-661.
25. Oliviero U, Bonadies G, Apuzzi V, Foggia M, Bosso G, Nappa S, ValVano A, Leonardi E, Borgia G, Castello G, Napoli R, Sacca L. Human immunodeficiency virus per se exerts atherogenic effects. Atherosclerosis 2009;204: 586-589.